Robert G Bristow Selected Research

Robert G Bristow Research Topics

Disease

90	Neoplasms (Cancer) 01/2022 - 05/2003
80	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 12/2004
36	Hypoxia (Hypoxemia) 01/2022 - 10/2004
14	Neoplasm Metastasis (Metastasis) 10/2021 - 10/2010
9	Breast Neoplasms (Breast Cancer) 04/2020 - 01/2010
7	Urinary Bladder Neoplasms (Bladder Cancer) 02/2019 - 07/2007
5	Genomic Instability 11/2021 - 12/2014
5	Carcinoma (Carcinomatosis) 09/2020 - 09/2005
4	Adenocarcinoma 01/2019 - 05/2012
3	Carcinogenesis 01/2020 - 12/2005
3	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2012 - 09/2002
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 10/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 11/2012
2	Triple Negative Breast Neoplasms 01/2017 - 01/2016
2	Lung Neoplasms (Lung Cancer) 01/2016 - 06/2012
2	Chromosomal Instability (Chromosome Stability) 01/2014 - 01/2012
2	Tics (Tic) 01/2012 - 01/2010
1	Stress Fractures (Stress Fracture) 01/2022
1	Disease Progression 09/2020
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2019
1	Circulating Neoplastic Cells 01/2019
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2018

Drug/Important Bio-Agent (IBA)

29	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2004
19	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2003
17	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2007
12	AndrogensIBA 01/2021 - 09/2005
10	Oxygen (Dioxygen)IBA 01/2020 - 01/2006
8	Messenger RNA (mRNA)IBA 10/2021 - 10/2004
8	RNA (Ribonucleic Acid)IBA 10/2021 - 08/2005
8	Prostate-Specific Antigen (Semenogelase)IBA 01/2021 - 09/2005
8	Biological ProductsIBA 01/2016 - 03/2008
7	ChromatinIBA 12/2021 - 12/2005
7	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020 - 08/2008
7	Pharmaceutical PreparationsIBA 01/2018 - 03/2013
7	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 09/2013 - 08/2005
6	NucleotidesIBA 11/2021 - 07/2015
6	Radiation-Sensitizing AgentsIBA 07/2021 - 06/2010
6	Cisplatin (Platino)FDA LinkGeneric 02/2019 - 07/2007
5	Hormones (Hormone)IBA 01/2022 - 02/2011
4	olaparibIBA 04/2020 - 09/2015
4	GoldIBA 01/2017 - 06/2010
4	Small Interfering RNA (siRNA)IBA 01/2016 - 01/2008
3	AntigensIBA 01/2022 - 10/2010
3	MicroRNAs (MicroRNA)IBA 01/2020 - 12/2013
3	Prostaglandins AIBA 01/2018 - 08/2012
3	Long Noncoding RNAIBA 11/2017 - 10/2016
3	Metformin (Glucophage)FDA LinkGeneric 01/2016 - 09/2010
3	Mitomycin (Mitomycin-C)FDA LinkGeneric 08/2014 - 12/2004
3	AMP-Activated Protein KinasesIBA 03/2012 - 09/2010
2	Radioisotopes (Radionuclides)IBA 01/2021 - 05/2013
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 09/2017
2	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 01/2019
2	Complement System Proteins (Complement)IBA 01/2018 - 12/2014
2	Phenobarbital (Luminal)FDA Link 01/2017 - 05/2012
2	Kallikreins (Kallikrein)IBA 01/2017 - 01/2017
2	PlatinumIBA 01/2016 - 06/2012
2	Phosphotransferases (Kinase)IBA 12/2013 - 06/2011
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 12/2013 - 10/2010
2	Imatinib Mesylate (Gleevec)FDA Link 03/2013 - 01/2009
2	Green Fluorescent ProteinsIBA 10/2011 - 01/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2007 - 08/2005
1	LigandsIBA 01/2022
1	Vitamin K 3 (Menadione)FDA Link 07/2021
1	Gemcitabine FDA Link 07/2021
1	lissamine rhodamine B (sulforhodamine B)IBA 07/2021
1	CXC ChemokinesIBA 09/2020
1	2- (3- (1- carboxy- 5- ((6- fluoropyridine- 3- carbonyl)amino)pentyl)ureido)pentanedioic acidIBA 01/2020
1	ProdrugsIBA 01/2019
1	TH 302IBA 01/2019
1	Circulating Tumor DNAIBA 01/2019
1	Circular RNAIBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	ProteomeIBA 01/2019
1	Niacinamide (Nicotinamide)FDA LinkGeneric 05/2018
1	carbogenIBA 05/2018
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2018
1	Investigational DrugsIBA 01/2018
1	serratiopeptidaseIBA 10/2017
1	Serine Proteases (Serine Protease)IBA 01/2017
1	Tissue Kallikreins (Tissue Kallikrein)IBA 01/2017
1	N 563IBA 01/2017
1	Plasma KallikreinIBA 01/2017
1	bicalutamide (Casodex)FDA LinkGeneric 08/2016
1	Beclin-1IBA 01/2016

Therapy/Procedure

60	Radiotherapy 01/2022 - 07/2003
48	Therapeutics 01/2022 - 05/2003
11	Drug Therapy (Chemotherapy) 10/2017 - 07/2007
10	Image-Guided Radiotherapy 01/2019 - 09/2008
8	Castration 01/2022 - 02/2015
7	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 07/2008
4	Neoadjuvant Therapy 02/2019 - 07/2007
3	Immunotherapy 01/2021 - 01/2018
3	Chemoradiotherapy 02/2019 - 08/2009
3	Cystectomy 02/2019 - 09/2010
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2017 - 09/2009
2	Laser Therapy (Surgery, Laser) 01/2016 - 01/2006
2	Precision Medicine 02/2015 - 09/2010
2	Electrodes (Electrode) 09/2009 - 06/2007
1	Cytoreduction Surgical Procedures 01/2021
1	Transurethral Resection of Bladder 07/2017